Nanoscale Materials to Target Diseases in the Vasculature Cardiovascular disease is the leading cause of mortality globally, with inflammation-inducing atherosclerotic plaque being the main contributing factor. The CANTOS trial showed that decreasing inflammation reduced cardiovascular events without lowering lipids, but … Read More
The causal role of cancer in atherosclerosis Cancer and cardiovascular disease are the world’s leading killers. They share many overlapping risk factors, but emerging data suggest potential causal relationships. This lecture will describe new evidence suggesting that each disease may … Read More
Katie - Humoral-immune mediated cardiac dysfunction in a novel model of peripartum cardiomyopathy AJ - Impaired Clearance of TTR Amyloid in the Hearts of Males with Loss of the Y Chromosome Madison -
Immune checkpoints in atherosclerosis: a new VISTA I will talk about the role of co-stimulatory and coinhibitory immune checkpoints in atherosclerosis. Not only will I highlight the dangers of immune checkpoint inhibition in cancer treatment on the vasculature, I will … Read More
Cardiac Mesenchymal Cells as Regulators of Vascular Function Our research focuses on cellular interactions within the developing and injured coronary vasculature, with an emphasis on how epicardium-derived mesenchymal cells and cardiac pericytes regulate angiogenesis, vascular stability, and fibrotic remodeling. We … Read More
TBD Florence Irving Assistant Professor of Medical Sciences, Cardiometabolic Genomics Program, Div. of Cardiology, Dept. of Medicine, Columbia University Irving Medical Center, New York, NY
TBD Postdoctoral Research Fellow, Wolf Lab, University of Virginia, Charlottesville, VA
TBD
